N-3 fatty acids: priority for post-myocardial infarction clinical trials.
Grundy
Scott M
SM
D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D019587:Dietary Supplements; D004435:Eating; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control*; D055502:Secondary Prevention
D000889:Anti-Arrhythmia Agents; D015525:Fatty Acids, Omega-3